Major players in the community oncology services market are Community Care Physicians P.C., Nebraska Cancer Specialists, US Oncology, Inc. (McKesson Corporation), Tufts Medical Center, Doctors Medical Center, Oncology Specialists, S.C., and Baptist Cancer Center.
The global community oncology services market is expected to decline from $70.98 billion in 2020 to $70.78 billion in 2021 at a compound annual growth rate (CAGR) of -0.3%. The slow decline is attributed to COVID-19 restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $69.97 billion in 2025 at a CAGR of -0.2%.
The community oncology services market consists of sales of community oncology services by entities (organizations, sole traders and partnerships) of health practitioners who practice community oncology as a private physician-owned business not part of a hospital or academic or medical teaching institution.The community oncology practice may be only a single oncologist, with one office and a support staff of physician extenders, nurses, pharmacists, or pharmacy technicians and other staff.
Only goods and services traded between entities or sold to end consumers are included.
The community oncology services market covered in this report is segmented by type into small community oncology clinics, medium community oncology clinics, large community oncology clinics; cancer type into breast cancer, lung cancer, kidney cancer, liver cancer, ovarian cancer, prostate cancer, skin cancer, pancreatic cancer, blood cancer, colorectal cancer, others.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Coronavirus outbreak is likely to act as a major restraint for the growth of the community oncology services market during the forecast period.The World Health Organization (WHO) declared the COVID-19 outbreak as pandemic on March 11, 2020.
Coronavirus has created a significant risk of mortality for cancer patients worldwide.COVID-19 is predicted to have a long-term impact on oncology practices.
According to a survey conducted by the Medical Group Management Association in April 2020, the healthcare practices recorded a decline of 55% in the revenue and a 60% decline in the patient volume since the beginning of the COVID-19 pandemic.Moreover, according to a survey of 51 USA oncologists conducted by MJH Life Sciences during May 2020, 73% of the oncologist limited their surgeries to urgent cases, 53% modified dosing regimens to reduce in-patient visits, and 71% had canceled routine office visits of the patients.
Therefore, the coronavirus outbreak has caused a rapid decline in overall oncology in-person services, subsequently impacting the community oncology services market.
In May 2019, Amgen announced its decision to collaborate with community oncology service providers such as US Oncology Research and TRIO-US to enhance access by community centers to innovative oncology clinical research. This collaboration is expected to allow Amgen to significantly expand its clinical research footprint to more than 200 patient care sites across the U.S. and help community centers reach more than 900,000 new patients each year with investigational medicines.
The lower-cost care in community oncology centers is anticipated to boost the demand for the community oncology service market.The cancer care services are considered to be cost-effective in community oncology centers as compared to hospitals.
According to the Community Oncology Alliance’s report published in October 2018, the cost of cancer care per patient per month for various tumors in community-based clinics (CCs) was approximately $12,000 whereas the cost of cancer care in hospital-based oncology clinics (HCs) was about $20,000.Furthermore, the cost per patient per month for treatment of chemotherapy in a community setting was nearly $5,000 compared to around $8,500 in hospital-based clinics.
Hence, the low cost of community oncology settings or community oncology centers is expected to drive the demand for the community oncology services market over the forecast years.
Major companies are undergoing various acquisition and research collaboration in the community oncology services market to expand their services and offerings, which is gaining significant popularity over the recent years. According to a report published by Community Oncology Alliance in April 2020, the rate of community oncology practices acquired by hospitals increased by 9.7% during 2018 and 2020. For instance, in August 2020, The Community Cancer Center, a US-based clinic engaged in providing community-based cancer care, was acquired by Carle Health. Carle Health is a US-based hospital and healthcare company with more than 9,500 employees in its five hospitals and associated healthcare business. In addition to this, in May 2019, Amgen Inc., a US-based biopharmaceutical company, announced the new research collaborations with community oncology networks. Amgen Inc., also launched Amgen Community Oncology Research Collaborators (ACORC), a new initiative to improve access to innovative oncology clinical research for community centers.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Our reports have been used by over 10K customers, including:
BPO Services Retail Global Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025 Summary Global BPO Services industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains...
The dental diamond burs market size is projected to grow from USD 130 million in 2021 to USD 191 million by 2026, at a CAGR of 8.0%. The dental diamond burs market is witnessing high growth owing to the increase in the consciousness to dental and oral health and versatility of the dental industry to provide specific and optimum services to...
The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. Factors such as decline in the fertility rates worldwide, increase adoption of different infertility procedures, rising number of fertility clinics worldwide, rise in public...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the fertility treatment market are Apollo Hospitals Enterprise Ltd., Care Fertility Group, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Progyny Inc., Vitrolife, Carolinas Fertility Institute and OvaScience Inc. The global fertility treatments market is expected to grow from...
Value-based care (VBC) model aims at providing better outcome and care quality to patients in a cost-effective manner. The revenue risk and incentive for providing better value could be shared between multiple stakeholders including payers, healthcare providers, medical technology participants, and others. The study focuses on providing...
Sports Medicine Market, Global Forecast, Impact of COVID-19, Industry Trends, by Product Type, Growth, Opportunity Company Analysis Sports medicine is a type of medicine that focuses on improving people’s athletic abilities. Sport medicine products aid in the recovery of injuries as well as the prevention...
The global ventricular assist device market exhibited strong growth during 2015-2020. A ventricular assist device (VAD), also known as a mechanical circulatory support device, is a mechanical pump that transports blood from the lower chambers of the heart to the rest of the body. It generally comprises three components,...
The global radiopharmaceuticals market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The Global Healthcare Video Conferencing Solutions Market size is expected to reach $120.3 Million by 2027, rising at a market growth of 6.6% CAGR during the forecast period. Healthcare video conferencing is also known as telemedicine. It is a way through which healthcare professionals communicate with their patients over the internet. With...
This IDC Perspective illustrates how NHS National Services Scotland designed and delivered a vaccine scheduling and management system to rapidly distribute COVID-19 vaccines safely and effectively to its 5.5 million citizens across the country. To achieve national vaccination plan goals, NHS Scotland was required to quickly and effectively...
Health Care Provider
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.